Lipid-modulating drugs statins (HMG-CoA reductase inhibitors) are a milestone to lower cholesterol levels in blood and become one of the most powerful pharmacological strategies in the treatment of cardiovascular diseases [16]. Here, HMGCR is linked to cardiovascular disorder.